Document
falsefalse--12-31--12-31Q3Q3201720172017-09-302017-09-3010-Q10-Q00015745400001583994179218618YesNoLarge Accelerated FilerNon-accelerated FilerPhysicians Realty TrustPhysicians Realty L.P.P1Y021152910.230.015000000001359660131792087861359660131792087860.00850.0140.010.01550.0120.0180.00900.01450.01550.01250.0120.018850000000400000000750000001500000002500000000.0430.04240.04090.04740.04030.02871359660131792087861359660131792087860000343620753799813436207537998100P90DP3YP1YP2YP3Y 0001574540 2017-01-01 2017-09-30 0001574540 doc:PhysiciansRealtyLPMember 2017-01-01 2017-09-30 0001574540 2017-10-31 0001574540 2016-12-31 0001574540 2017-09-30 0001574540 2016-07-01 2016-09-30 0001574540 2016-01-01 2016-09-30 0001574540 2017-07-01 2017-09-30 0001574540 us-gaap:NoncontrollingInterestMember 2017-01-01 2017-09-30 0001574540 us-gaap:RetainedEarningsMember 2017-01-01 2017-09-30 0001574540 doc:OperatingPartnershipNoncontrollingInterestMember 2017-01-01 2017-09-30 0001574540 us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-09-30 0001574540 doc:OperatingPartnershipNoncontrollingInterestMember 2016-12-31 0001574540 us-gaap:CommonStockMember 2017-01-01 2017-09-30 0001574540 doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2016-12-31 0001574540 us-gaap:ParentMember 2017-01-01 2017-09-30 0001574540 doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2017-09-30 0001574540 doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2017-01-01 2017-09-30 0001574540 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2016-12-31 0001574540 doc:OperatingPartnershipNoncontrollingInterestMember 2017-09-30 0001574540 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0001574540 us-gaap:ParentMember 2016-12-31 0001574540 us-gaap:RetainedEarningsMember 2016-12-31 0001574540 us-gaap:NoncontrollingInterestMember 2016-12-31 0001574540 us-gaap:RetainedEarningsMember 2017-09-30 0001574540 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2017-01-01 2017-09-30 0001574540 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2017-09-30 0001574540 us-gaap:ParentMember 2017-09-30 0001574540 us-gaap:CommonStockMember 2016-12-31 0001574540 us-gaap:CommonStockMember 2017-09-30 0001574540 us-gaap:AdditionalPaidInCapitalMember 2017-09-30 0001574540 us-gaap:NoncontrollingInterestMember 2017-09-30 0001574540 2015-12-31 0001574540 2016-09-30 0001574540 doc:PhysiciansRealtyLPMember 2017-09-30 0001574540 doc:PhysiciansRealtyLPMember 2016-12-31 0001574540 doc:PhysiciansRealtyLPMember 2017-07-01 2017-09-30 0001574540 doc:PhysiciansRealtyLPMember 2016-01-01 2016-09-30 0001574540 doc:PhysiciansRealtyLPMember 2016-07-01 2016-09-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:LimitedPartnerMember 2017-01-01 2017-09-30 0001574540 doc:PhysiciansRealtyLPMember doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2017-01-01 2017-09-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:LimitedPartnerMember 2017-09-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0001574540 doc:PhysiciansRealtyLPMember doc:PartnersCapitalMember 2016-12-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:GeneralPartnerMember 2017-01-01 2017-09-30 0001574540 doc:PhysiciansRealtyLPMember doc:PartnersCapitalMember 2017-01-01 2017-09-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:GeneralPartnerMember 2017-09-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:GeneralPartnerMember 2016-12-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-09-30 0001574540 doc:PhysiciansRealtyLPMember doc:PartnersCapitalMember 2017-09-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:LimitedPartnerMember 2016-12-31 0001574540 doc:PhysiciansRealtyLPMember doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2016-12-31 0001574540 doc:PhysiciansRealtyLPMember doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2017-09-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-09-30 0001574540 doc:PhysiciansRealtyLPMember 2016-09-30 0001574540 doc:PhysiciansRealtyLPMember 2015-12-31 0001574540 2017-03-31 0001574540 2017-07-01 2017-07-31 0001574540 2017-03-01 2017-03-31 0001574540 us-gaap:SubsequentEventMember 2017-10-31 0001574540 doc:A2016ATMProgramMember us-gaap:MaximumMember us-gaap:PrivatePlacementMember 2016-08-05 2016-08-05 0001574540 2017-07-31 0001574540 doc:A2016ATMProgramMember 2017-04-01 2017-06-30 0001574540 doc:A2016ATMProgramMember 2017-01-01 2017-03-31 0001574540 doc:A2016ATMProgramMember 2017-01-01 2017-09-30 0001574540 doc:A2016ATMProgramMember 2017-07-01 2017-09-30 0001574540 doc:NashvilleMOBMember 2015-12-17 2015-12-17 0001574540 doc:TermLoanReceivableMember 2017-09-30 0001574540 doc:MezzanineLoanReceivableMember 2017-09-30 0001574540 us-gaap:SeriesAPreferredStockMember 2015-02-05 0001574540 2015-03-01 2015-03-01 0001574540 2017-09-21 2017-09-21 0001574540 2015-03-01 0001574540 us-gaap:SeriesAPreferredStockMember 2015-02-05 2015-02-05 0001574540 doc:PhysiciansRealtyLPMember us-gaap:PartnershipInterestMember 2017-03-31 0001574540 doc:PhysiciansRealtyLPMember doc:JointventureOperatingPartnershipandMedicalCenterofNewAlbanyILLCMember us-gaap:PartnershipInterestMember 2017-01-31 2017-01-31 0001574540 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2017-09-30 0001574540 doc:JointventureOperatingPartnershipandMedicalCenterofNewAlbanyILLCMember 2017-01-31 2017-01-31 0001574540 doc:JointventureOperatingPartnershipandMedicalCenterofNewAlbanyILLCMember 2017-01-31 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2017-01-01 2017-09-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember 2017-01-01 2017-09-30 0001574540 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2017-01-01 2017-09-30 0001574540 doc:MinnetonkaMOBMember us-gaap:PartnershipInterestMember 2016-04-01 0001574540 doc:MinnetonkaMOBMember 2015-02-05 2015-02-05 0001574540 2017-01-12 0001574540 doc:NashvilleMOBMember 2017-01-12 2017-01-12 0001574540 doc:PhysiciansRealtyLPMember 2017-01-01 2017-03-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:PartnershipInterestMember 2017-01-01 2017-03-31 0001574540 2017-04-01 2017-06-30 0001574540 doc:ClearviewCancerInstituteMember 2017-08-04 2017-08-04 0001574540 doc:LoanInvestmentsMember 2017-07-01 2017-09-30 0001574540 doc:HonorHealthMesaMOBMember 2017-08-15 2017-08-15 0001574540 doc:LegendsParkMOBASCMember 2017-09-27 2017-09-27 0001574540 doc:NorthsideCherokeeTowneLakeMOBMember 2017-08-15 2017-08-15 0001574540 doc:A2017CHIPortfolioTranche25MOBsMember 2017-08-24 2017-08-31 0001574540 doc:NoncontrollingInterestBuyoutGreatFallsClinicMember 2017-09-21 2017-09-21 0001574540 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2017-01-01 2017-09-30 0001574540 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2017-07-01 2017-09-30 0001574540 us-gaap:LoansMember 2017-01-01 2017-09-30 0001574540 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember doc:GeorgiaPortfolioMember 2017-02-23 2017-02-23 0001574540 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember doc:PeachtreeDunwoodyMedicalCenterMember 2017-08-15 0001574540 doc:NoncontrollingInterestBuyoutGreatFallsClinicMember 2017-07-21 0001574540 doc:LoanInvestmentsMember 2017-09-30 0001574540 doc:BusinessCombinationAcquisitionPeriodThreeMember us-gaap:LeasesAcquiredInPlaceMember 2017-09-30 0001574540 doc:BusinessCombinationAcquisitionPeriodOneMember doc:BelowMarketLeasesMember 2017-03-31 0001574540 doc:BusinessCombinationAcquisitionPeriodTwoMember doc:AbovemarketinplacegroundleaseMember 2017-06-30 0001574540 doc:BusinessCombinationAcquisitionPeriodTwoMember 2017-06-30 0001574540 doc:AbovemarketinplacegroundleaseMember 2017-09-30 0001574540 doc:BelowMarketGroundLeaseMember 2017-09-30 0001574540 doc:BusinessCombinationAcquisitionPeriodOneMember us-gaap:LeasesAcquiredInPlaceMember 2017-03-31 0001574540 doc:BusinessCombinationAcquisitionPeriodThreeMember 2017-09-30 0001574540 us-gaap:AboveMarketLeasesMember 2017-09-30 0001574540 doc:BusinessCombinationAcquisitionPeriodTwoMember doc:BelowMarketGroundLeaseMember 2017-06-30 0001574540 doc:BusinessCombinationAcquisitionPeriodOneMember 2017-03-31 0001574540 doc:BusinessCombinationAcquisitionPeriodTwoMember us-gaap:LeasesAcquiredInPlaceMember 2017-06-30 0001574540 doc:BusinessCombinationAcquisitionPeriodThreeMember doc:AbovemarketinplacegroundleaseMember 2017-09-30 0001574540 doc:BusinessCombinationAcquisitionPeriodThreeMember doc:BelowMarketGroundLeaseMember 2017-09-30 0001574540 doc:BusinessCombinationAcquisitionPeriodOneMember doc:AbovemarketinplacegroundleaseMember 2017-03-31 0001574540 doc:BusinessCombinationAcquisitionPeriodOneMember us-gaap:AboveMarketLeasesMember 2017-03-31 0001574540 doc:BusinessCombinationAcquisitionPeriodTwoMember doc:BelowMarketLeasesMember 2017-06-30 0001574540 doc:BusinessCombinationAcquisitionPeriodTwoMember us-gaap:AboveMarketLeasesMember 2017-06-30 0001574540 us-gaap:LeasesAcquiredInPlaceMember 2017-09-30 0001574540 doc:BusinessCombinationAcquisitionPeriodOneMember doc:BelowMarketGroundLeaseMember 2017-03-31 0001574540 doc:BusinessCombinationAcquisitionPeriodThreeMember us-gaap:AboveMarketLeasesMember 2017-09-30 0001574540 doc:BusinessCombinationAcquisitionPeriodThreeMember doc:BelowMarketLeasesMember 2017-09-30 0001574540 doc:BelowMarketLeasesMember 2017-09-30 0001574540 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember doc:GeorgiaPortfolioMember 2016-01-01 2016-09-30 0001574540 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember doc:GeorgiaPortfolioMember 2016-07-01 2016-09-30 0001574540 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember doc:GeorgiaPortfolioMember 2017-07-01 2017-09-30 0001574540 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember doc:GeorgiaPortfolioMember 2017-01-01 2017-09-30 0001574540 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember doc:PeachtreeDunwoodyMedicalCenterMember 2017-08-15 2017-08-15 0001574540 doc:BelowMarketLeasesMember 2016-01-01 2016-09-30 0001574540 us-gaap:AboveMarketLeasesMember 2016-01-01 2016-09-30 0001574540 us-gaap:AboveMarketLeasesMember 2017-01-01 2017-09-30 0001574540 doc:BelowMarketGroundLeaseMember 2016-07-01 2016-09-30 0001574540 us-gaap:AboveMarketLeasesMember 2017-07-01 2017-09-30 0001574540 doc:BelowMarketGroundLeaseMember 2016-01-01 2016-09-30 0001574540 us-gaap:LeasesAcquiredInPlaceMember 2016-07-01 2016-09-30 0001574540 doc:LeaseholdInterestMember 2016-01-01 2016-09-30 0001574540 doc:LeaseholdInterestMember 2016-07-01 2016-09-30 0001574540 us-gaap:AboveMarketLeasesMember 2016-07-01 2016-09-30 0001574540 us-gaap:LeasesAcquiredInPlaceMember 2017-01-01 2017-09-30 0001574540 doc:AboveMarketGroundLeaseMember 2016-07-01 2016-09-30 0001574540 us-gaap:LeasesAcquiredInPlaceMember 2016-01-01 2016-09-30 0001574540 doc:AboveMarketGroundLeaseMember 2017-01-01 2017-09-30 0001574540 doc:BelowMarketLeasesMember 2017-07-01 2017-09-30 0001574540 doc:LeaseholdInterestMember 2017-07-01 2017-09-30 0001574540 doc:BelowMarketLeasesMember 2017-01-01 2017-09-30 0001574540 doc:BelowMarketGroundLeaseMember 2017-07-01 2017-09-30 0001574540 doc:LeaseholdInterestMember 2017-01-01 2017-09-30 0001574540 doc:AboveMarketGroundLeaseMember 2016-01-01 2016-09-30 0001574540 doc:BelowMarketGroundLeaseMember 2017-01-01 2017-09-30 0001574540 us-gaap:LeasesAcquiredInPlaceMember 2017-07-01 2017-09-30 0001574540 doc:BelowMarketLeasesMember 2016-07-01 2016-09-30 0001574540 doc:AboveMarketGroundLeaseMember 2017-07-01 2017-09-30 0001574540 doc:LeaseholdInterestMember 2017-09-30 0001574540 us-gaap:AboveMarketLeasesMember 2016-12-31 0001574540 doc:BelowMarketGroundLeaseMember 2016-12-31 0001574540 doc:AboveMarketGroundLeaseMember 2017-09-30 0001574540 doc:BelowMarketLeasesMember 2016-12-31 0001574540 us-gaap:LeasesAcquiredInPlaceMember 2016-12-31 0001574540 doc:LeaseholdInterestMember 2016-12-31 0001574540 doc:AboveMarketGroundLeaseMember 2016-12-31 0001574540 doc:CreditratingbelowBBBorBAA3Member doc:BaseRateLoansMember doc:TermLoanMember us-gaap:BaseRateMember 2017-01-01 2017-09-30 0001574540 doc:CreditratingatleastBBBplusorBAA1Member doc:BaseRateLoansMember us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2017-01-01 2017-09-30 0001574540 doc:CreditratingatleastBBBorBAA3Member doc:BaseRateLoansMember us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2017-01-01 2017-09-30 0001574540 doc:CreditratingbelowBBBorBAA3Member doc:BaseRateLoansMember us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2017-01-01 2017-09-30 0001574540 doc:CreditratingatleastAorA3Member doc:BaseRateLoansMember us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2017-01-01 2017-09-30 0001574540 doc:CreditratingatleastBBBorBAA2Member doc:BaseRateLoansMember us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2017-01-01 2017-09-30 0001574540 doc:CreditratingatleastBBBorBAA3Member doc:BaseRateLoansMember doc:TermLoanMember us-gaap:BaseRateMember 2017-01-01 2017-09-30 0001574540 doc:CreditratingatleastAorA3Member doc:BaseRateLoansMember doc:TermLoanMember us-gaap:BaseRateMember 2017-01-01 2017-09-30 0001574540 doc:CreditratingatleastBBBorBAA2Member doc:BaseRateLoansMember doc:TermLoanMember us-gaap:BaseRateMember 2017-01-01 2017-09-30 0001574540 doc:CreditratingatleastBBBplusorBAA1Member doc:BaseRateLoansMember doc:TermLoanMember us-gaap:BaseRateMember 2017-01-01 2017-09-30 0001574540 us-gaap:SeniorNotesMember 2017-03-07 2017-03-07 0001574540 us-gaap:SeniorNotesMember 2017-01-26 0001574540 doc:MortgageNotesBearingVariableInterestDueIn2017and2018Member us-gaap:MortgagesMember 2016-12-31 0001574540 doc:SeriesCMember us-gaap:SeniorNotesMember 2016-08-11 0001574540 us-gaap:RevolvingCreditFacilityMember 2017-09-30 0001574540 doc:CreditAgreementAmendmentMember us-gaap:RevolvingCreditFacilityMember us-gaap:MinimumMember 2016-06-09 0001574540 us-gaap:SeriesAMember us-gaap:SeniorNotesMember 2016-01-07 0001574540 doc:CreditAgreementAmendmentMember 2016-06-10 2016-06-10 0001574540 doc:CreditAgreementAmendmentMember us-gaap:RevolvingCreditFacilityMember us-gaap:MaximumMember 2016-06-10 0001574540 us-gaap:SeriesBMember 2016-01-07 0001574540 us-gaap:SeniorNotesMember 2017-03-07 0001574540 doc:CreditAgreementAmendmentMember us-gaap:LondonInterbankOfferedRateLIBORMember 2016-06-10 2016-06-10 0001574540 doc:MortgageNotesBearingVariableInterestDueIn2017and2018Member us-gaap:MortgagesMember us-gaap:MaximumMember us-gaap:LondonInterbankOfferedRateLIBORMember 2016-01-01 2016-12-31 0001574540 us-gaap:SeriesAMember 2016-01-07 0001574540 doc:MortgageNotesBearingVariableInterestDueIn2017and2018Member us-gaap:MortgagesMember 2017-09-30 0001574540 doc:SeriesCMember us-gaap:SeniorNotesMember 2016-01-07 0001574540 doc:MortgageNotesBearingFixedInterestRateDueIn201720182019202020212022and2032And2022Member us-gaap:MortgagesMember us-gaap:MinimumMember 2016-12-31 0001574540 doc:MortgageNotesBearingVariableInterestDueIn2017and2018Member us-gaap:MortgagesMember us-gaap:MaximumMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-01-01 2017-09-30 0001574540 us-gaap:InterestRateSwapMember us-gaap:UnsecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2016-07-07 0001574540 doc:SeriesDMember us-gaap:SeniorNotesMember 2016-01-07 0001574540 doc:MortgageNotesBearingVariableInterestDueIn2017and2018Member us-gaap:MortgagesMember us-gaap:MinimumMember us-gaap:LondonInterbankOfferedRateLIBORMember 2016-01-01 2016-12-31 0001574540 us-gaap:SeriesAMember us-gaap:SeniorNotesMember 2016-08-11 0001574540 us-gaap:SeriesAMember 2016-08-11 0001574540 doc:MortgageNotesBearingVariableInterestDueIn2017and2018Member us-gaap:MortgagesMember us-gaap:MinimumMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-01-01 2017-09-30 0001574540 doc:MortgageNotesBearingFixedInterestRateDueIn201720182019202020212022and2032And2022Member us-gaap:MortgagesMember us-gaap:MinimumMember 2017-09-30 0001574540 doc:CreditAgreementAmendmentMember 2016-06-10 0001574540 us-gaap:SeniorNotesMember 2016-01-07 0001574540 us-gaap:SeriesBMember 2016-08-11 0001574540 doc:TermLoanMember 2016-07-07 0001574540 us-gaap:SeriesBMember us-gaap:SeniorNotesMember 2016-01-07 0001574540 us-gaap:SeriesBMember us-gaap:SeniorNotesMember 2016-08-11 0001574540 doc:SeriesCMember 2016-01-07 0001574540 doc:CreditAgreementAmendmentMember doc:TermLoanMember 2016-06-10 2016-06-10 0001574540 us-gaap:SeniorNotesMember 2016-08-11 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RevolvingCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-01-01 2017-09-30 0001574540 doc:MortgageNotesBearingFixedInterestRateDueIn201720182019202020212022and2032And2022Member us-gaap:MortgagesMember us-gaap:MaximumMember 2016-12-31 0001574540 doc:SeriesDMember 2016-01-07 0001574540 us-gaap:LetterOfCreditMember 2017-09-30 0001574540 doc:TermLoanMember 2017-09-30 0001574540 doc:MortgageNotesBearingFixedInterestRateDueIn201720182019202020212022and2032And2022Member us-gaap:MortgagesMember 2017-09-30 0001574540 doc:MortgageNotesBearingFixedInterestRateDueIn201720182019202020212022and2032And2022Member us-gaap:MortgagesMember us-gaap:MaximumMember 2017-09-30 0001574540 doc:MortgageNotesBearingFixedInterestRateDueIn201720182019202020212022and2032And2022Member us-gaap:MortgagesMember 2016-12-31 0001574540 doc:BankSNBNationalAssociationMember us-gaap:MortgagesMember 2017-09-30 0001574540 doc:CreditAgreementAmendmentMember doc:TermLoanMember 2016-06-10 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RevolvingCreditFacilityMember 2017-09-30 0001574540 us-gaap:MortgagesMember 2017-09-30 0001574540 doc:SeniorUnsecuredNotesDueAugust2025to2027Member us-gaap:SeniorNotesMember 2016-12-31 0001574540 doc:UnsecuredNotesBearingFixedInterestDueJanuary2023to2031Member us-gaap:SeniorNotesMember 2016-12-31 0001574540 doc:UnsecuredTermLoanDueJune2023Member us-gaap:UnsecuredDebtMember 2016-12-31 0001574540 doc:RevolvingCreditFacilityDueSeptember2020Member us-gaap:RevolvingCreditFacilityMember 2016-12-31 0001574540 doc:SeniorUnsecuredNoteDue2027Member us-gaap:SeniorNotesMember 2017-09-30 0001574540 doc:RevolvingCreditFacilityDueSeptember2020Member us-gaap:RevolvingCreditFacilityMember 2017-09-30 0001574540 doc:SeniorUnsecuredNotesDueAugust2025to2027Member us-gaap:SeniorNotesMember 2017-09-30 0001574540 doc:SeniorUnsecuredNoteDue2027Member us-gaap:SeniorNotesMember 2016-12-31 0001574540 us-gaap:MortgagesMember 2016-12-31 0001574540 doc:UnsecuredNotesBearingFixedInterestDueJanuary2023to2031Member us-gaap:SeniorNotesMember 2017-09-30 0001574540 doc:MortgageNotesBearingVariableInterestMember us-gaap:MortgagesMember 2016-12-31 0001574540 doc:MortgageNotesBearingVariableInterestMember us-gaap:MortgagesMember 2017-09-30 0001574540 doc:UnsecuredTermLoanDueJune2023Member us-gaap:UnsecuredDebtMember 2017-09-30 0001574540 doc:UnsecuredTermLoanDueJune2023Member us-gaap:UnsecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-01-01 2017-09-30 0001574540 us-gaap:RevolvingCreditFacilityMember 2016-06-10 2016-06-10 0001574540 doc:CreditratingatleastAorA3Member doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-01-01 2017-09-30 0001574540 doc:CreditratingatleastAorA3Member doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-01-01 2017-09-30 0001574540 doc:CreditratingatleastBBBorBAA2Member doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-01-01 2017-09-30 0001574540 doc:CreditratingbelowBBBorBAA3Member doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-01-01 2017-09-30 0001574540 doc:CreditratingatleastBBBplusorBAA1Member doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-01-01 2017-09-30 0001574540 doc:CreditratingatleastBBBorBAA3Member doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-01-01 2017-09-30 0001574540 doc:CreditratingatleastBBBplusorBAA1Member doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-01-01 2017-09-30 0001574540 doc:CreditratingatleastBBBorBAA3Member doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-01-01 2017-09-30 0001574540 doc:CreditratingatleastBBBorBAA2Member doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-01-01 2017-09-30 0001574540 doc:CreditratingbelowBBBorBAA3Member doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-01-01 2017-09-30 0001574540 doc:SeniorUnsecuredNotesDueAugust2025to2027Member us-gaap:SeniorNotesMember us-gaap:MaximumMember 2017-09-30 0001574540 doc:SeniorUnsecuredNotesDueAugust2025to2027Member us-gaap:SeniorNotesMember us-gaap:MinimumMember 2017-09-30 0001574540 doc:UnsecuredNotesBearingFixedInterestDueJanuary2023to2031Member us-gaap:SeniorNotesMember us-gaap:MinimumMember 2017-09-30 0001574540 doc:RevolvingCreditFacilityDueSeptember2020Member us-gaap:RevolvingCreditFacilityMember 2017-01-01 2017-09-30 0001574540 doc:UnsecuredNotesBearingFixedInterestDueJanuary2023to2031Member us-gaap:SeniorNotesMember us-gaap:MaximumMember 2017-09-30 0001574540 doc:UnsecuredTermLoanDueJune2023Member us-gaap:UnsecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2016-07-07 2016-07-07 0001574540 us-gaap:InterestRateSwapMember 2017-01-26 0001574540 us-gaap:InterestRateSwapMember 2017-03-07 2017-03-07 0001574540 us-gaap:InterestRateSwapMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001574540 us-gaap:InterestRateSwapMember 2016-07-07 0001574540 2016-07-07 0001574540 us-gaap:InterestRateSwapMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2017-09-30 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2017-01-01 2017-09-30 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2016-12-31 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2017-09-30 0001574540 doc:PerformanceBasedRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2017-07-01 2017-09-30 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2017-07-01 2017-09-30 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember us-gaap:DirectorMember 2017-03-31 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2014-08-07 2014-08-07 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember 2017-01-01 2017-09-30 0001574540 doc:ExecutiveAwardsRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2017-09-30 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2014-08-07 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2016-01-01 2016-09-30 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember 2016-07-01 2016-09-30 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember 2016-01-01 2016-09-30 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember us-gaap:OfficerMember 2017-03-01 2017-03-31 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember 2017-07-01 2017-09-30 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember 2017-09-30 0001574540 doc:MarketBasedRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember us-gaap:OfficerMember 2017-03-01 2017-03-31 0001574540 doc:TrusteeAwardsRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember us-gaap:DirectorMember 2016-03-01 2016-03-31 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2013-07-24 0001574540 doc:ExecutiveAwardsRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2017-01-01 2017-09-30 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2016-07-01 2016-09-30 0001574540 doc:TrusteeAwardsRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2017-01-01 2017-09-30 0001574540 doc:ExecutiveAwardsRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2016-12-31 0001574540 doc:TrusteeAwardsRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2016-12-31 0001574540 doc:TrusteeAwardsRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2017-09-30 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember us-gaap:DirectorMember 2017-01-01 2017-09-30 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember us-gaap:OfficerMember 2017-01-01 2017-09-30 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember us-gaap:MaximumMember 2017-01-01 2017-09-30 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember us-gaap:MinimumMember 2017-01-01 2017-09-30 0001574540 us-gaap:FairValueMeasurementsNonrecurringMember 2017-09-30 0001574540 us-gaap:InterestRateSwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2017-09-30 0001574540 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2017-09-30 0001574540 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001574540 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2017-09-30 0001574540 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001574540 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001574540 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2017-09-30 0001574540 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001574540 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2017-09-30 0001574540 us-gaap:InterestRateSwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001574540 us-gaap:OperatingExpenseMember doc:ParkingAirAndGroundLeasesMember 2017-01-01 2017-09-30 0001574540 us-gaap:OperatingExpenseMember doc:ParkingAirAndGroundLeasesMember 2016-01-01 2016-09-30 0001574540 us-gaap:OperatingExpenseMember doc:ParkingAirAndGroundLeasesMember 2016-07-01 2016-09-30 0001574540 us-gaap:OperatingExpenseMember doc:ParkingAirAndGroundLeasesMember 2017-07-01 2017-09-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember stpr:NE 2017-01-01 2017-09-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember doc:AllotherstatesMember 2017-01-01 2017-09-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember stpr:IN 2017-01-01 2017-09-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember stpr:AZ 2017-01-01 2017-09-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember stpr:TX 2017-01-01 2017-09-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember stpr:KY 2017-01-01 2017-09-30 0001574540 us-gaap:SalesRevenueServicesNetMember 2017-01-01 2017-09-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember doc:USOncologyMember 2017-01-01 2017-09-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember doc:BaylorScottandWhiteHealthMember 2017-01-01 2017-09-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember doc:CHINebraskaMember 2017-01-01 2017-09-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember doc:CHISt.AlexiusNorthDakotaMember 2017-01-01 2017-09-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember doc:RemainingPortfolioMember 2017-01-01 2017-09-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember doc:CHIKentuckyOneHealthMember 2017-01-01 2017-09-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember doc:CHIPortfolioMember 2017-01-01 2017-09-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember doc:TopfivetenantrelationshipsMember 2017-01-01 2017-09-30 0001574540 us-gaap:RestrictedStockMember 2016-07-01 2016-09-30 0001574540 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-09-30 0001574540 us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-09-30 0001574540 us-gaap:RestrictedStockUnitsRSUMember 2017-07-01 2017-09-30 0001574540 us-gaap:RestrictedStockMember 2017-07-01 2017-09-30 0001574540 us-gaap:RestrictedStockMember 2017-01-01 2017-09-30 0001574540 us-gaap:RestrictedStockUnitsRSUMember 2016-07-01 2016-09-30 0001574540 us-gaap:RestrictedStockMember 2016-01-01 2016-09-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RestrictedStockMember 2017-01-01 2017-09-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RestrictedStockMember 2016-01-01 2016-09-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RestrictedStockUnitsRSUMember 2016-07-01 2016-09-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RestrictedStockMember 2016-07-01 2016-09-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RestrictedStockUnitsRSUMember 2017-07-01 2017-09-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RestrictedStockMember 2017-07-01 2017-09-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-09-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-09-30 0001574540 doc:PhysiciansRealtyLPMember doc:DavisPortfolio2.02MOBsMember us-gaap:SubsequentEventMember 2017-10-10 2017-10-10 0001574540 us-gaap:SubsequentEventMember 2017-10-10 2017-10-31 0001574540 doc:PhysiciansRealtyLPMember doc:FranklinMOBASCMember us-gaap:SubsequentEventMember 2017-10-10 2017-10-10 doc:instruments doc:properties iso4217:USD xbrli:shares xbrli:pure doc:buildings xbrli:shares iso4217:USD doc:mezzanine_loan doc:parking_deck utreg:Rate doc:states doc:healthcareproperty doc:condominium_units doc:acquisitions doc:segment utreg:sqft
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
 
FORM 10-Q
 
 

☒    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended September 30, 2017
 
or
 
☐    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from             to
 
Commission file number: 001-36007 (Physicians Realty Trust)
Commission file number: 333-205034-01 (Physicians Realty L.P.)
 
 
 
PHYSICIANS REALTY TRUST
PHYSICIANS REALTY L.P.
(Exact Name of Registrant as Specified in its Charter)
 
 
Maryland (Physicians Realty Trust)
Delaware (Physicians Realty L.P.)
(State of Organization)
 
46-2519850
80-0941870
(IRS Employer Identification No.)
 
 
 
309 N. Water Street,
Suite 500
Milwaukee, Wisconsin
(Address of Principal Executive Offices)
 
53202
(Zip Code)
 
(414) 367-5600
(Registrant’s Telephone Number, Including Area Code) 
 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Physicians Realty Trust        Yes ý No o            Physicians Realty L.P.        Yes o No ý    

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). 
Physicians Realty Trust        Yes ý No o            Physicians Realty L.P.        Yes o No ý
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Physicians Realty Trust
Large accelerated filer ý     Accelerated filer o Non-accelerated filer o (Do not check if a smaller reporting company) Smaller reporting company o Emerging growth company o

Physicians Realty L.P.
Large accelerated filer o     Accelerated filer o Non-accelerated filer ý (Do not check if a smaller reporting company) Smaller reporting company o Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Physicians Realty Trust      o Physicians Realty L.P. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). 
Physicians Realty Trust        Yes o No ý         Physicians Realty L.P.        Yes o No ý

The number of the Registrant’s common shares outstanding as of October 31, 2017 was 179,218,618.
 



EXPLANATORY NOTE

This Quarterly Report on Form 10-Q combines the Quarterly Reports on Form 10-Q for the quarter ended  September 30, 2017 of Physicians Realty Trust (the “Trust”), a Maryland real estate investment trust, and Physicians Realty L.P. (the “Operating Partnership”), a Delaware limited partnership. Unless otherwise indicated or unless the context requires otherwise, all references in this report to “we,” “us,” “our,” and the “Company,” refer to the Trust, together with its consolidated subsidiaries, including the Operating Partnership. References to the “Operating Partnership” mean collectively the Operating Partnership, together with its consolidated subsidiaries. In this report, all references to “common shares” refer to the common shares of the Trust and references to “our shareholders” refer to shareholders of the common shares of the Trust, the term “OP Units” refers to partnership interests of the Operating Partnership and the term “Series A Preferred Units” refers to Series A Participating Redeemable Preferred Units of the Operating Partnership. As of October 31, 2017, no Series A Preferred Units are outstanding.

The Trust is a self-managed real estate investment trust (“REIT”) formed primarily to acquire, selectively develop, own, and manage healthcare properties that are leased to physicians, hospitals, and healthcare delivery systems. The Trust’s operations are conducted through the Operating Partnership and wholly-owned and majority-owned subsidiaries of the Operating Partnership. The Trust, as the general partner of the Operating Partnership, controls the Operating Partnership and consolidates the assets, liabilities, and results of operations of the Operating Partnership.

The Trust conducts substantially all of its operations through the Operating Partnership. As of September 30, 2017, the Trust held a 97.1% interest in the Operating Partnership and owns no Series A Preferred Units. Apart from this ownership interest, the Trust has no independent operations.

Noncontrolling interests in the Operating Partnership, shareholders’ equity of the Trust and partners’ capital of the Operating Partnership are the primary areas of difference between the consolidated financial statements of the Trust and those of the Operating Partnership. OP Units not owned by the Trust are accounted for as limited partners’ capital in the Operating Partnership’s consolidated financial statements and as noncontrolling interests in the Trust’s consolidated financial statements. The differences between the Trust’s shareholders’ equity and the Operating Partnership’s partners’ capital are due to the differences in the equity issued by the Trust and the Operating Partnership, respectively.

The Company believes combining the Quarterly Reports of the Trust and the Operating Partnership, including the notes to the consolidated financial statements, into this single report results in the following benefits:

a combined report enhances investors’ understanding of the Trust and the Operating Partnership by enabling investors to view the business as a whole in the same manner as management views and operates the business;
a combined report eliminates duplicative disclosure and provides a more streamlined and readable presentation, as a substantial portion of the Company’s disclosure applies to both the Trust and the Operating Partnership; and
a combined report creates time and cost efficiencies through the preparation of one combined report instead of two separate reports.

To help investors understand the significant differences between the Trust and the Operating Partnership, this report presents the following separate sections for each of the Trust and the Operating Partnership:

the consolidated financial statements in Part I, Item 1 of this report;
certain accompanying notes to the consolidated financial statements, including Note 3 (Acquisitions and Dispositions) and Note 14 (Earnings Per Share and Earnings Per Unit);
controls and procedures in Part I, Item 4 of this report; and
the certifications of the Chief Executive Officer and the Chief Financial Officer included as Exhibits 31 and 32 to this report.



Table of Contents

PHYSICIANS REALTY TRUST AND PHYSICIANS REALTY L.P.
 
Quarterly Report on Form 10-Q
for the Quarter Ended September 30, 2017
 
Table of Contents
 
 

 
 
Page Number
 
 
 
 
 
 
 
 
Financial Statements of Physicians Realty Trust
 
 
 
 
 
 
 
 
 
Financial Statements of Physicians Realty L.P.
 
 
 
 
 
 
 
 
 
Notes for Physicians Realty Trust and Physicians Realty L.P.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


Table of Contents

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
 
This Quarterly Report on Form 10-Q contains forward-looking statements made pursuant to safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts may be forward-looking statements within the meaning of the federal securities laws. In particular, statements pertaining to our capital resources, property performance and results of operations contain forward-looking statements. Likewise, all of our statements regarding anticipated growth in our funds from operations and anticipated market conditions, demographics and results of operations are forward-looking statements. You can identify forward-looking statements by the use of forward-looking terminology such as “believe,” “expect,” “outlook,” “continue,” “project,” “may,” “will,” “should,” “seek,” “approximately,” “intend,” “plan,” “pro forma,” “estimate” or “anticipate” or the negative of these words and phrases or similar words or phrases which are predictions of or indicate future events or trends and which do not relate solely to historical matters. You can also identify forward-looking statements by discussions of strategy, plans, expectations or intentions.
 
These forward-looking statements reflect the views of our management regarding current expectations and projections about future events and are based on currently available information. These forward-looking statements are not guarantees of future performance and involve numerous risks and uncertainties and you should not rely on them as predictions of future events. Forward-looking statements depend on assumptions, data or methods which may be incorrect or imprecise and we may not be able to realize them. We do not guarantee that the transactions and events described will happen as described (or that they will happen at all). The following factors, among others, could cause actual results and future events to differ materially from those set forth or contemplated in the forward-looking statements:
 
general economic conditions;

adverse economic or real estate developments, either nationally or in the markets where our properties are located;

our failure to generate sufficient cash flows to service our outstanding indebtedness, or our ability to pay down or refinance our indebtedness;

fluctuations or increases in interest rates;

fluctuations or increases in operating costs;

the availability, terms and deployment of debt and equity capital, including our unsecured revolving credit facility;

our ability to make distributions on our common shares;

general volatility of the market price of our common shares;

our increased vulnerability economically due to the concentration of our investments in healthcare properties;

our geographic concentration in Texas causes us to be particularly exposed to downturns in the Texas economy or other changes in Texas market conditions;

changes in our business or strategy;

our dependence upon key personnel whose continued service is not guaranteed;

our ability to identify, hire and retain highly qualified personnel in the future;

the degree and nature of our competition;

changes in governmental regulations or interpretations thereof, such as real estate and zoning laws and increases in real property tax rates and taxation of REITs, and similar matters;

defaults on or non-renewal of leases by tenants;

decreased rental rates or increased vacancy rates;
 
difficulties in identifying healthcare properties to acquire and completing acquisitions;

1

Table of Contents


competition for investment opportunities;

any adverse effects to Catholic Health Initiatives’ (“CHI”) business, financial position or results of operations that impact the ability of affiliates of CHI to pay us rent;

our failure to successfully develop, integrate and operate acquired properties and operations;

the impact of our investments in joint ventures;

the financial condition and liquidity of, or disputes with, any joint venture and development partners with whom we may make co-investments in the future;

cybersecurity incidents could disrupt our business and result in the compromise of confidential information;

our ability to operate as a public company;

changes in accounting principles generally accepted in the United States (GAAP);
 
lack of or insufficient amounts of insurance;
 
other factors affecting the real estate industry generally;

our failure to maintain our qualification as a REIT for U.S. federal income tax purposes;
 
limitations imposed on our business and our ability to satisfy complex rules in order for us to qualify as a REIT for U.S. federal income tax purposes; and
 
various other factors that may materially adversely affect us, or the per share trading price of our common shares, including:
 
the number of our common shares available for future issuance or sale;
our issuance of equity securities or the perception that such issuance might occur;
future debt;
failure of securities analysts to publish research or reports about us or our industry; and
securities analysts’ downgrade of our common shares or the healthcare-related real estate sector.

While forward-looking statements reflect our good faith beliefs, they are not guarantees of future performance. We disclaim any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this report, except as required by applicable law. You should not place undue reliance on any forward-looking statements that are based on information currently available to us or the third parties making the forward-looking statements. For a further discussion of these and other factors that could impact our future results, performance or transactions, see Part II, Item 1A (Risk Factors) of this report, Part I, Item 1A (Risk Factors) of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016 (the “2016 Annual Report”), and Part II, Item 1A (Risk Factors) of our Quarterly Report on Form 10-Q for the quarterly periods ended March 31, 2017 (the “First Quarterly Report”), and June 30, 2017 (the “Second Quarterly Report”, and together with the First Quarterly Report, the “2017 Quarterly Reports”).

2

Table of Contents

PART I.                         Financial Information
Item 1.                             Financial Statements
Physicians Realty Trust
Consolidated Balance Sheets
(In thousands, except share and per share data)
 
September 30,
2017
 
December 31,
2016
 
(unaudited)
 
 
ASSETS
 

 
 

Investment properties:
 

 
 

Land and improvements
$
204,305

 
$
189,759

Building and improvements
3,255,900

 
2,402,643

Tenant improvements
20,786

 
14,133

Acquired lease intangibles
402,608

 
301,462

 
3,883,599


2,907,997

Accumulated depreciation
(263,497
)
 
(181,785
)
Net real estate property
3,620,102


2,726,212

Real estate loans receivable
78,944

 
39,154

Investment in unconsolidated entities
2,232

 
2,258

Net real estate investments
3,701,278


2,767,624

Cash and cash equivalents
4,924

 
15,491

Tenant receivables, net
8,389

 
9,790

Other assets
123,909

 
95,187

Total assets
$
3,838,500


$
2,888,092

LIABILITIES AND EQUITY
 

 
 

Liabilities:
 

 
 

Credit facility
$
382,960

 
$
643,742

Notes payable
619,793

 
224,330

Mortgage debt
169,464

 
123,083

Accounts payable
6,590

 
4,423

Dividends and distributions payable
43,452

 
32,179

Accrued expenses and other liabilities
51,421

 
42,287

Acquired lease intangibles, net
15,680

 
9,253

Total liabilities
1,289,360


1,079,297

 
 
 
 
Redeemable noncontrolling interest - Series A Preferred Units (2016) and partially owned properties
10,919

 
26,477

 
 
 
 
Equity:
 

 
 

Common shares, $0.01 par value, 500,000,000 common shares authorized, 179,208,786 and 135,966,013 common shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively
1,792

 
1,360

Additional paid-in capital
2,732,121

 
1,920,644

Accumulated deficit
(282,019
)
 
(197,261
)
Accumulated other comprehensive income
12,012

 
13,708

Total shareholders’ equity
2,463,906


1,738,451

Noncontrolling interests:
 

 
 

Operating Partnership
73,688

 
43,142

Partially owned properties
627

 
725

Total noncontrolling interests
74,315


43,867

Total equity
2,538,221


1,782,318

Total liabilities and equity
$
3,838,500


$
2,888,092


The accompanying notes are an integral part of these consolidated financial statements.

3

Table of Contents

Physicians Realty Trust
Consolidated Statements of Income
(In thousands, except share and per share data) (Unaudited)
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2017
 
2016
 
2017
 
2016
Revenues:
 

 
 

 
 

 
 

Rental revenues
$
69,408

 
$
53,327

 
$
186,515

 
$
130,378

Expense recoveries
21,102

 
14,361

 
53,564

 
31,816

Interest income on real estate loans and other
2,489

 
2,322

 
6,185

 
5,166

Total revenues
92,999


70,010


246,264


167,360

Expenses:
 

 
 

 
 

 
 

Interest expense
11,998

 
7,300

 
33,285

 
15,776

General and administrative
5,860

 
4,917

 
16,845

 
13,964

Operating expenses
27,471

 
19,159

 
70,079

 
43,994

Depreciation and amortization
32,975

 
23,969

 
89,031

 
59,778

Acquisition expenses
2,184

 
4,398

 
12,831

 
11,031

Total expenses
80,488


59,743


222,071


144,543

Income before equity in income of unconsolidated entities and gain on sale of investment properties:
12,511

 
10,267

 
24,193

 
22,817

Equity in income of unconsolidated entities
28

 
27

 
85

 
85

Gain on sale of investment properties

 

 
5,308

 

Net income
12,539


10,294


29,586


22,902

Net income attributable to noncontrolling interests:
 

 
 

 
 

 
 

Operating Partnership
(362
)
 
(255
)
 
(823
)
 
(629
)
Partially owned properties (1)
(53
)
 
(176
)
 
(379
)
 
(553
)
Net income attributable to controlling interests
12,124


9,863


28,384


21,720

Preferred distributions
(106
)
 
(436
)
 
(505
)
 
(1,421
)
Net income attributable to common shareholders:
$
12,018


$
9,427


$
27,879


$
20,299

Net income per share:
 

 
 

 
 

 
 

Basic
$
0.07

 
$
0.07

 
$
0.18

 
$
0.17

Diluted
$
0.07

 
$
0.07

 
$
0.18

 
$
0.16

Weighted average common shares:
 

 
 

 
 

 
 

Basic
177,847,424

 
134,608,396

 
157,542,167

 
122,973,862

Diluted
183,298,145

 
138,880,787

 
162,480,918

 
127,395,989

 
 
 
 
 
 
 
 
Dividends and distributions declared per common share and OP Unit
$
0.230

 
$
0.225

 
$
0.685

 
$
0.675

(1)
Includes amounts attributable to redeemable noncontrolling interests. No such adjustments are required for the three and nine months ended September 30, 2016.

The accompanying notes are an integral part of these consolidated financial statements.

4

Table of Contents

Physicians Realty Trust
Consolidated Statements of Comprehensive Income
(In thousands) (Unaudited)
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2017
 
2016
 
2017
 
2016
Net income
$
12,539

 
$
10,294

 
$
29,586

 
$
22,902

Other comprehensive income:
 
 
 
 
 
 
 
Change in fair value of interest rate swap agreements
(916
)
 
652

 
(1,696
)
 
652

Total other comprehensive income
(916
)
 
652

 
(1,696
)
 
652

Comprehensive income
11,623

 
10,946

 
27,890

 
23,554

Comprehensive income attributable to noncontrolling interests - Operating Partnership
(339
)
 
(272
)
 
(774
)
 
(646
)
Comprehensive income attributable to noncontrolling interests - partially owned properties
(53
)
 
(176
)
 
(379
)
 
(553
)
Comprehensive income attributable to common shareholders
$
11,231

 
$
10,498

 
$
26,737

 
$
22,355


The accompanying notes are an integral part of these consolidated financial statements.

5

Table of Contents

Physicians Realty Trust
Consolidated Statement of Equity
(In thousands) (Unaudited)

 
Par
Value
 
Additional
Paid in
Capital
 
Accumulated
Deficit
 
Accumulated Other Comprehensive Income
 
Total
Shareholders’ 
Equity
 
Operating
Partnership
Noncontrolling
Interest
 
Partially
Owned
Properties 
Noncontrolling
Interest
 
Total
Noncontrolling
Interests
 
Total
Equity
Balance at January 1, 2017
$
1,360

 
$
1,920,644

 
$
(197,261
)
 
$
13,708

 
$
1,738,451

 
$
43,142

 
$
725

 
$
43,867

 
$
1,782,318

Net proceeds from sale of common shares
430

 
804,023

 

 

 
804,453

 

 

 

 
804,453

Restricted share award grants, net
2

 
2,391

 
(473
)
 

 
1,920

 

 

 

 
1,920

Purchase of OP Units

 

 

 

 

 
(3,757
)
 

 
(3,757
)
 
(3,757
)
Conversion of OP Units

 
783

 

 

 
783

 
(783
)
 

 
(783
)
 

Dividends/distributions declared

 

 
(112,164
)
 

 
(112,164
)
 
(3,635
)
 

 
(3,635
)
 
(115,799
)
Preferred distributions

 

 
(505
)
 

 
(505
)
 

 

 

 
(505
)
Issuance of OP Units in connection with acquisitions

 

 

 

 

 
44,259

 

 
44,259

 
44,259

Contributions

 

 

 

 

 

 
47

 
47

 
47

Distributions

 

 

 

 

 

 
(266
)
 
(266
)
 
(266
)
Buyout of Noncontrolling Interests - partially owned properties

 
(2,800
)
 

 

 
(2,800
)
 
719

 
(24
)
 
695

 
(2,105
)
Change in fair value of interest rate cap agreements

 

 

 
(1,696
)
 
(1,696
)
 

 

 

 
(1,696
)
Net income

 

 
28,384

 

 
28,384

 
823

 
145

 
968

 
29,352

Adjustment for Noncontrolling Interests ownership in Operating Partnership

 
7,080

 

 

 
7,080

 
(7,080
)
 

 
(7,080
)
 

Balance at September 30, 2017
$
1,792


$
2,732,121


$
(282,019
)

$
12,012

 
$
2,463,906


$
73,688


$
627


$
74,315


$
2,538,221

 
The accompanying notes are an integral part of this consolidated financial statement.



6

Table of Contents

Physicians Realty Trust
Consolidated Statements of Cash Flows
(In thousands) (Unaudited)
 
Nine Months Ended
September 30,
 
2017
 
2016
Cash Flows from Operating Activities:
 

 
 

Net income
$
29,586

 
$
22,902

Adjustments to reconcile net income to net cash provided by operating activities
 
 
 

Depreciation and amortization
89,031

 
59,778

Amortization of deferred financing costs
1,731

 
1,796

Amortization of lease inducements and above/below market lease intangibles
3,780

 
2,994

Straight-line rental revenue/expense
(11,168
)
 
(12,156
)
Amortization of discount on unsecured senior notes
177

 

Amortization of above market assumed debt
(163
)
 
(177
)
Gain on sale of investment properties
(5,308
)
 

Equity in income of unconsolidated entities
(85
)
 
(85
)
Distributions from unconsolidated entities
112

 
82

Change in fair value of derivative
160

 
(67
)
Provision for bad debts
(297
)
 
152

Non-cash share compensation
4,976

 
3,497

Net change in fair value of contingent consideration
4

 
(840
)
Change in operating assets and liabilities:
 

 
 

Tenant receivables
(754
)
 
(7,543
)
Other assets
(541
)
 
(6,320
)
Accounts payable
2,167

 
1,578

Accrued expenses and other liabilities
14,834

 
23,832

Net cash provided by operating activities
128,242


89,423

Cash Flows from Investing Activities:
 

 
 

Proceeds on sales of investment properties
18,150

 

Acquisition of investment properties, net
(916,270
)
 
(1,044,601
)
Escrowed cash - acquisition / earnest deposits
(25,271
)
 

Capital expenditures on existing investment properties
(14,819
)
 
(8,665
)
Real estate loans receivable
(38,844
)
 
(8,153
)
Repayment of note receivable
16,423

 
4,118

Repayment of real estate loan receivable
1,507

 
4,500

Leasing commissions
(1,184
)
 
(707
)
Lease inducements
(2,508
)
 
(4,870
)
Net cash used in investing activities
(962,816
)

(1,058,378
)
Cash Flows from Financing Activities:
 

 
 

Net proceeds from sale of common shares
804,453

 
764,292

Proceeds from credit facility borrowings
627,000

 
921,000

Payment on credit facility borrowings
(889,000
)
 
(860,000
)
Proceeds from issuance of mortgage debt
61,000

 
21,500

Proceeds from issuance of senior unsecured notes
396,108

 
225,000

Principal payments on mortgage debt
(40,999
)
 
(1,646
)
Debt issuance costs
(1,129
)
 
(4,693
)
Dividends paid - shareholders
(101,846
)
 
(74,515
)
Distributions to noncontrolling interest - Operating Partnership
(3,154
)
 
(2,410
)
Preferred distributions paid - OP Unit holder
(519
)
 
(1,115
)
Contributions from noncontrolling interest
47

 

Distributions to noncontrolling interest - partially owned properties
(1,653
)
 
(450
)
Other financing activities
(2,583
)
 

Purchase of Series A Preferred Units
(19,961
)
 
(9,756
)
Purchase of OP Units
(3,757
)
 
(2,999
)
Net cash provided by financing activities
824,007


974,208

Net (decrease) increase in cash and cash equivalents
(10,567
)
 
5,253

Cash and cash equivalents, beginning of period
15,491

 
3,143

Cash and cash equivalents, end of period
$
4,924


$
8,396

Supplemental disclosure of cash flow information - interest paid during the period
$
33,307

 
$
6,971

Supplemental disclosure of noncash activity - change in fair value of interest rate swap agreements
$
(1,696
)
 
$
652

Supplemental disclosure of noncash activity - assumed debt
$
26,379

 
$

Supplemental disclosure of noncash activity - issuance of OP Units in connection with acquisitions
$
44,978

 
$
6,769

Supplemental disclosure of noncash activity - contingent consideration
$

 
$
156

The accompanying notes are an integral part of these consolidated financial statements.

7

Table of Contents

Physicians Realty L.P.
Consolidated Balance Sheets
(In thousands, except unit and per unit data)
 
September 30,
2017
 
December 31, 2016
 
(unaudited)
 
 
ASSETS
 

 
 

Investment properties:
 
 
 
Land and improvements
$
204,305

 
$
189,759

Building and improvements
3,255,900

 
2,402,643

Tenant improvements
20,786

 
14,133

Acquired lease intangibles
402,608

 
301,462

 
3,883,599

 
2,907,997

Accumulated depreciation
(263,497
)
 
(181,785
)
Net real estate property
3,620,102

 
2,726,212

Real estate loans receivable
78,944

 
39,154

Investment in unconsolidated entities
2,232

 
2,258

Net real estate investments
3,701,278

 
2,767,624

Cash and cash equivalents
4,924

 
15,491

Tenant receivables, net
8,389

 
9,790

Other assets
123,909

 
95,187

Total assets
$
3,838,500

 
$
2,888,092

LIABILITIES AND CAPITAL
 
 
 
Liabilities:
 
 
 
Credit facility
$
382,960

 
$
643,742

Notes payable
619,793

 
224,330

Mortgage debt
169,464

 
123,083

Accounts payable
6,590

 
4,423

Dividends and distributions payable
43,452

 
32,179

Accrued expenses and other liabilities
51,421

 
42,287

Acquired lease intangibles, net
15,680

 
9,253

Total liabilities
1,289,360

 
1,079,297

 
 
 
 
Redeemable noncontrolling interest - Series A Preferred Units (2016) and partially owned properties
10,919

 
26,477

 
 
 
 
Capital:
 
 
 
Partners’ capital:
 
 
 
General partners’ capital, 179,208,786 and 135,966,013 units issued and outstanding as of September 30, 2017 and December 31, 2016, respectively
2,451,894

 
1,724,743

Limited partners’ capital, 5,379,981 and 3,436,207 units issued and outstanding as of September 30, 2017 and December 31, 2016, respectively
73,688

 
43,142

Accumulated other comprehensive income
12,012

 
13,708

Total partners’ capital
2,537,594

 
1,781,593

Noncontrolling interest - partially owned properties
627

 
725

Total capital
2,538,221

 
1,782,318

Total liabilities and capital
$
3,838,500

 
$
2,888,092


The accompanying notes are an integral part of these consolidated financial statements.


8

Table of Contents

Physicians Realty L.P.
Consolidated Statements of Income
(In thousands, except unit and per unit data) (Unaudited)
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2017
 
2016
 
2017
 
2016
Revenues:
 

 
 

 
 

 
 

Rental revenues
$
69,408

 
$
53,327

 
$
186,515

 
$
130,378

Expense recoveries
21,102

 
14,361

 
53,564

 
31,816

Interest income on real estate loans and other
2,489

 
2,322

 
6,185

 
5,166

Total revenues
92,999

 
70,010

 
246,264

 
167,360

Expenses:
 
 
 
 
 
 
 
Interest expense
11,998

 
7,300

 
33,285

 
15,776

General and administrative
5,860

 
4,917

 
16,845

 
13,964

Operating expenses
27,471

 
19,159

 
70,079

 
43,994

Depreciation and amortization
32,975

 
23,969

 
89,031

 
59,778

Acquisition expenses
2,184

 
4,398

 
12,831

 
11,031

Total expenses
80,488

 
59,743

 
222,071

 
144,543

Income before equity in income of unconsolidated entities and gain on sale of investment properties:
12,511

 
10,267

 
24,193

 
22,817

Equity in income of unconsolidated entities
28

 
27

 
85

 
85

Gain on sale of investment properties

 

 
5,308

 

Net income
12,539

 
10,294

 
29,586

 
22,902

Net income attributable to noncontrolling interests - partially owned properties (1)
(53
)
 
(176
)
 
(379
)
 
(553
)
Net income attributable to controlling interests
12,486

 
10,118

 
29,207

 
22,349

Preferred distributions
(106
)
 
(436
)
 
(505
)
 
(1,421
)
Net income attributable to common unitholders
$
12,380

 
$
9,682

 
$
28,702

 
$
20,928

Net income per common unit:
 
 
 
 
 
 
 
Basic
$
0.07

 
$
0.07

 
$
0.18

 
$
0.17

Diluted
$
0.07

 
$
0.07

 
$
0.18

 
$
0.16

Weighted average common units:
 
 
 
 
 
 
 
Basic
183,227,405

 
138,227,384

 
162,205,324

 
126,751,876

Diluted
183,298,145

 
138,880,787

 
162,480,918

 
127,395,989

 
 
 
 
 
 
 
 
Distributions declared per common unit
$
0.230

 
$
0.225

 
$
0.685

 
$
0.675

(1)
Includes amounts attributable to redeemable noncontrolling interests. No such adjustments are required for the three and nine months ended September 30, 2016.

The accompanying notes are an integral part of these consolidated financial statements.


9

Table of Contents

Physicians Realty L.P.
Consolidated Statements of Comprehensive Income
(In thousands) (Unaudited)
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2017
 
2016
 
2017
 
2016
Net income
$
12,539

 
$
10,294

 
$
29,586

 
$
22,902

Other comprehensive income:
 
 
 
 
 
 
 
Change in fair value of interest rate swap agreements
(916
)
 
652

 
(1,696
)
 
652

Total other comprehensive income
(916
)
 
652

 
(1,696
)
 
652

Comprehensive income
11,623

 
10,946

 
27,890

 
23,554

Comprehensive income attributable to noncontrolling interests - partially owned properties
(53
)
 
(176
)
 
(379
)
 
(553
)
Comprehensive income attributable to common unitholders
$
11,570

 
$
10,770

 
$
27,511

 
$
23,001


The accompanying notes are an integral part of these consolidated financial statements.


10

Table of Contents

Physicians Realty L.P.
Consolidated Statement of Changes in Capital
(In thousands) (Unaudited)
 
General Partner
 
Limited Partner
 
Accumulated Other Comprehensive Income
 
Total
Partners’ Capital
 
Partially
Owned
Properties
Noncontrolling
Interest
 
Total
Partners’ Capital
Balance at January 1, 2017
1,724,743

 
43,142

 
13,708

 
1,781,593

 
725

 
1,782,318

Net proceeds from sale of common shares
804,453

 

 

 
804,453